Skip Navigation
Skip to contents

대한신장학회


간행물 검색

현재 페이지 경로
  • HOME
  • 간행물
  • 간행물 검색
논문분류 춘계학술대회 초록집
제목 Lysyl-tRNA synthetase 1 Modulation Attenuates Renal Inflammation and Fibrosis in a Mouse Model of Chronic Kidney Disease
저자 Subin Lee
출판정보 2026; 2026(1):
키워드 Chronic Kidney Disease, Fibrosis, Inflammation, KARS1, Macrophage
초록 Objectives: Lysyl-tRNA synthetase 1 (KARS1) is an enzyme that catalyzes lysine attachment to tRNA during protein synthesis and has recently been recognized for its non-canonical role in immune signaling. Although KARS1 has been implicated in inflammatory and fibrotic liver diseases, its role in chronic kidney disease (CKD) remains unclear. Because CKD progression is driven by persistent inflammation and fibrosis leading to renal dysfunction, we hypothesized that KARS1 may contribute to these pathological processes in the kidney. Methods: CKD was induced in mice by administering a 0.2% adenine diet for two weeks. Animals were assigned to three groups (n = 6 per group): control, CKD, and CKD treated with the KARS1 modulator ZMC002(Zymedi), a small-molecule KARS1 modulator (25 mg/kg/day, oral administration). Renal KARS1 expression and cellular localization were examined using immunostaining with F4/80 and Lotus tetragonolobus lectin (LTL) markers. Circulating KARS1 levels were quantified by ELISA. Kidney function was assessed using blood urea nitrogen (BUN) and cystatin C. Tubular injury and fibrosis were evaluated by PAS and Masson’s trichrome staining. Expression of inflammatory and fibrotic markers was analyzed by qPCR and immunostaining. Statistical comparisons were performed using one-way ANOVA followed by Tukey’s multiple comparison test (p < 0.05). Results: CKD mice exhibited marked upregulation of KARS1, with prominent localization in macrophages and proximal tubular epithelial cells. Serum KARS1, BUN, and cystatin C levels were significantly elevated in CKD mice compared with controls but were substantially reduced following ZMC002 treatment. Histological analyses demonstrated significant tubular damage and interstitial fibrosis in CKD kidneys, both of which were attenuated by KARS1 modulation. Consistently, markers of tubular injury (VCAM-1), fibrosis (collagen I), macrophage activation (CD68, CD206), and inflammation (TNF-α) were significantly decreased in treated mice compared with untreated CKD animals. Conclusion: KARS1 is upregulated in CKD and contributes to renal inflammation and fibrosis. Its modulation effectively alleviates CKD-associated injury.
원문(PDF) PDF 원문보기
위로가기